Thank you to Randi Ervin, a volunteer with Pancreatic Cancer Action Network, as well as presenters from American Cancer Society, Susan G. Komen, The Partnership for Native American Cancer Prevention at Northern Arizona University and Patients Rising, and attendees for joining us at our #ASCO24 Patient Advocacy Connection Forum. Yesterday’s discussion focused on the important ways we can continue to make a positive impact for people affected by cancer and the #patientnavigation community.
About us
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ
- Website
-
http://merck.us/2J2xAUh
External link for Merck
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Rahway, New Jersey
- Type
- Public Company
- Specialties
- Pharmaceutical
Locations
-
Primary
126 E Lincoln Ave
P.O. Box 2000
Rahway, New Jersey 07065, US
-
351 N Sumneytown Pike
North Wales, PA 19454, US
Employees at Merck
Updates
-
Cancer remains one of the world’s greatest health challenges. We’re pursuing research where scientific opportunity and medical need converge, underpinned by our diverse pipeline across more than 30 tumor types. Learn more: http://merck.us/4aI4Nyt #ASCO24
-
Javon's experience with lupus felt isolating, underscoring the need for support. With an estimated 1.5 million Americans battling the disease, we remain committed to researching and developing treatments for autoimmune disorders. #LupusAwarenessMonth
-
Today, we announced an agreement to acquire EyeBio, a clinical-stage ophthalmology-focused biotech company, advancing novel investigational candidates for retinal diseases, including #diabeticmacularedema. This acquisition augments our pipeline and expands our research presence in #ophthalmology. http://merck.us/3R4nEvQ
-
Colleagues from our Asia Pacific Association (APA) employee business resource group (EBRG) are focused on encouraging compassionate leadership to inspire a culture of personal and professional growth. Learn how EBRGs like the APA empower our colleagues to develop a fulfilling career: http://merck.us/3yIvjJB #AANHPIHeritageMonth #PoweredByInclusion
-
Some of our leaders and Year Up colleagues met to discuss career development, the importance of diverse teams and the need for skills-focused job opportunities. Through unique opportunities like this, we’re mentoring and developing diverse leaders of tomorrow. Thank you Michael Klobuchar, Chirfi Guindo, Caroline Litchfield, Kenneth C. Frazier, Dean Y. Li, MD, PhD and Sean Curtis for your insights! Learn more about our skills-first approach to hiring diverse talent: http://merck.us/4dZYHvk #YearUp #DiversityandInclusion #MerckCareers
-
With talented colleagues like Luisiawati on our team, we’re committed to enhancing diversity in clinical trials so more people can experience better health outcomes. If you're passionate about making a difference in #ClinicalResearch, explore exciting career opportunities at our company: http://merck.us/4auDmXC #MerckCareers
Affiliated pages
Similar pages
Browse jobs
Stock
MRK
NYSE
20 minutes delay
$125.54
1.01 (0.811%)
- Open
- 125.13
- Low
- 124.55
- High
- 126.61
Data from Refinitiv
See more info on